FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022753971> ?p ?o ?g. }

• W2022753971 endingPage "e59531" @default.
• W2022753971 startingPage "e59531" @default.
• W2022753971 abstract "Human keratinocytes produce several antimicrobial peptides and proteins (AMP) which contribute to the protection of human skin against infection. RNase 7 is a major AMP involved in cutaneous defense with a high expression in keratinocytes and a broad spectrum of antimicrobial activity. The cytokine IL-17A has been recently identified as a potent inducer of several AMP in keratinocytes. Since the role of IL-17A to induce RNase 7 expression is unknown we analyzed IL-17A alone and in combination with other cytokines to induce RNase 7 expression in keratinocytes. Whereas IL-17A alone only weakly induced RNase 7 expression, the synergistic combination of IL-17A and IFN-γ (IL-17A/IFN-γ) was identified as a potent inducer of RNase 7 expression. This combination was more effective in inducing RNase 7 than the combination of IL-17A/TNF-α, a combination previously identified as a strong inducer of psoriasis-related immune response genes including several AMP. IFN-γ and IL-17A both have been reported to activate the transcription factor STAT3 (Signal transducer and activator of transcription 3). Therefore we investigated the influence of STAT3 on the IL-17A/IFN-γ -mediated RNase 7 induction. The use of a STAT3 inhibitor as well as siRNA-mediated downregulation of STAT3 resulted in a diminished IL-17A/IFN-γ -mediated RNase 7 induction in keratinocytes indicating that STAT3 is involved in this process. Similarly as seen with RNase 7, treatment of keratinocytes with IL-17A/IFN-γ revealed also a synergistic induction of gene expression of the AMP human beta-defensin (hBD)-2 and -3 as well as the S100 protein psoriasin (S100A7) indicating that the combination of IL-17A/IFN-γ is a potent inducer of various AMP classes in general. This was also reflected by an increase of the Staphylococcus aureus-killing activity of IL-17A/IFN-γ -treated keratinocytes." @default.
• W2022753971 created "2016-06-24" @default.
• W2022753971 creator A5038927076 @default.
• W2022753971 creator A5044433229 @default.
• W2022753971 creator A5062097412 @default.
• W2022753971 creator A5064719549 @default.
• W2022753971 creator A5071661573 @default.
• W2022753971 creator A5074088715 @default.
• W2022753971 date "2013-03-21" @default.
• W2022753971 modified "2023-10-11" @default.
• W2022753971 title "IL-17A and IFN-γ Synergistically Induce RNase 7 Expression via STAT3 in Primary Keratinocytes" @default.
• W2022753971 cites W1493141693 @default.
• W2022753971 cites W1560379370 @default.
• W2022753971 cites W1571292455 @default.
• W2022753971 cites W176879792 @default.
• W2022753971 cites W1964758221 @default.
• W2022753971 cites W1977160855 @default.
• W2022753971 cites W1978194636 @default.
• W2022753971 cites W1982481734 @default.
• W2022753971 cites W1986175684 @default.
• W2022753971 cites W1987287925 @default.
• W2022753971 cites W1991625690 @default.
• W2022753971 cites W2013075798 @default.
• W2022753971 cites W2019678439 @default.
• W2022753971 cites W2020799333 @default.
• W2022753971 cites W2031576296 @default.
• W2022753971 cites W2037759904 @default.
• W2022753971 cites W2044276427 @default.
• W2022753971 cites W2046388159 @default.
• W2022753971 cites W2056996834 @default.
• W2022753971 cites W2057231725 @default.
• W2022753971 cites W2060483617 @default.
• W2022753971 cites W2073865475 @default.
• W2022753971 cites W2075158987 @default.
• W2022753971 cites W2077604052 @default.
• W2022753971 cites W2078255866 @default.
• W2022753971 cites W2090042814 @default.
• W2022753971 cites W2092252407 @default.
• W2022753971 cites W2093308972 @default.
• W2022753971 cites W2103018315 @default.
• W2022753971 cites W2112267975 @default.
• W2022753971 cites W2118574276 @default.
• W2022753971 cites W2126516803 @default.
• W2022753971 cites W2138061716 @default.
• W2022753971 cites W2138502702 @default.
• W2022753971 cites W2139008734 @default.
• W2022753971 cites W2141016525 @default.
• W2022753971 cites W2141676495 @default.
• W2022753971 cites W2141987596 @default.
• W2022753971 cites W2144974645 @default.
• W2022753971 cites W2170540001 @default.
• W2022753971 cites W2171365939 @default.
• W2022753971 doi "https://doi.org/10.1371/journal.pone.0059531" @default.
• W2022753971 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3605401" @default.
• W2022753971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23555696" @default.
• W2022753971 hasPublicationYear "2013" @default.
• W2022753971 type Work @default.
• W2022753971 sameAs 2022753971 @default.
• W2022753971 citedByCount "38" @default.
• W2022753971 countsByYear W20227539712014 @default.
• W2022753971 countsByYear W20227539712015 @default.
• W2022753971 countsByYear W20227539712016 @default.
• W2022753971 countsByYear W20227539712017 @default.
• W2022753971 countsByYear W20227539712018 @default.
• W2022753971 countsByYear W20227539712019 @default.
• W2022753971 countsByYear W20227539712020 @default.
• W2022753971 countsByYear W20227539712021 @default.
• W2022753971 countsByYear W20227539712022 @default.
• W2022753971 countsByYear W20227539712023 @default.
• W2022753971 crossrefType "journal-article" @default.
• W2022753971 hasAuthorship W2022753971A5038927076 @default.
• W2022753971 hasAuthorship W2022753971A5044433229 @default.
• W2022753971 hasAuthorship W2022753971A5062097412 @default.
• W2022753971 hasAuthorship W2022753971A5064719549 @default.
• W2022753971 hasAuthorship W2022753971A5071661573 @default.
• W2022753971 hasAuthorship W2022753971A5074088715 @default.
• W2022753971 hasBestOaLocation W20227539711 @default.
• W2022753971 hasConcept C104317684 @default.
• W2022753971 hasConcept C10879258 @default.
• W2022753971 hasConcept C150194340 @default.
• W2022753971 hasConcept C153911025 @default.
• W2022753971 hasConcept C171958077 @default.
• W2022753971 hasConcept C203014093 @default.
• W2022753971 hasConcept C2225953 @default.
• W2022753971 hasConcept C2778690821 @default.
• W2022753971 hasConcept C2778923194 @default.
• W2022753971 hasConcept C47348012 @default.
• W2022753971 hasConcept C55493867 @default.
• W2022753971 hasConcept C62478195 @default.
• W2022753971 hasConcept C67705224 @default.
• W2022753971 hasConcept C86803240 @default.
• W2022753971 hasConcept C95444343 @default.
• W2022753971 hasConceptScore W2022753971C104317684 @default.
• W2022753971 hasConceptScore W2022753971C10879258 @default.
• W2022753971 hasConceptScore W2022753971C150194340 @default.
• W2022753971 hasConceptScore W2022753971C153911025 @default.
• W2022753971 hasConceptScore W2022753971C171958077 @default.
• W2022753971 hasConceptScore W2022753971C203014093 @default.

• next